Intravenous Iron Pre-treatment in Prognathic Surgery
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The objective of the present study is to determine the impact of preoperative IV-iron (ferric
carboxy maltose) supplementation on postoperative hematocrit values and allogenic blood
transfusion amount in patients undergoing elective prognathic surgery.